ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,071.63
      0.02%
      US Tech 100
      16,913.20
      -0.86%
      Dow Jones
      38,460.92
      -0.11%
      Brent Oil
      87.24
      0.02%
      Bitcoin
      63,958.40
      -0.50%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. TG Therapeutics Inc (TGTX)

      7. TG Therapeutics Inc (TGTX) News

      TGTX TG Therapeutics Inc

      13.98
      0.00 (0.00%)
      Pre Market
      Last Updated: 04:01:29
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      TG Therapeutics Inc TGTX NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 13.98 04:01:29
      Open Price Low Price High Price Close Price Prev Close
      13.98
      more quote information »

      Recent News

      Date Time Source Heading
      4/18/202407:30GLOBETG Therapeutics Announces Additional Data Presentations for..
      4/18/202407:00GLOBETG Therapeutics Awarded National Contract by the Department..
      4/15/202407:30GLOBETG Therapeutics Announces Presentation of Data for BRIUMVI®..
      3/08/202407:30GLOBETG Therapeutics Announces Schedule of Data Presentations for..
      3/01/202407:30GLOBETG Therapeutics Announces Presentation of Data for BRIUMVI®..
      2/29/202417:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
      2/28/202407:24EDGAR2Form 8-K - Current report
      2/28/202407:00GLOBETG Therapeutics Provides Business Update and Reports Fourth..
      2/27/202407:30GLOBETG Therapeutics Announces Issuance of Additional Patents for..
      2/26/202407:00GLOBETG Therapeutics Announces European Launch of BRIUMVI®..
      2/23/202407:30GLOBETG Therapeutics to Host Conference Call on Fourth Quarter..
      2/20/202407:30GLOBETG Therapeutics Announces Schedule of Data Presentations for..
      2/14/202421:53EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
      2/14/202415:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      1/26/202416:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      1/10/202407:37EDGAR2Form 8-K - Current report
      1/10/202407:00GLOBETG Therapeutics Provides Preliminary Fourth Quarter and Full..
      1/09/202409:20APSBiotech Massively Bid Up Before Opening Bell
      1/09/202407:00GLOBETG Therapeutics Announces Global License Agreement with..
      1/08/202418:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/08/202418:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/05/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/05/202411:02EDGAR2Form 144 - Report of proposed sale of securities
      1/05/202407:30GLOBETG Therapeutics to Participate in the 42nd Annual J.P...
      1/03/202416:46EDGAR2Form 144 - Report of proposed sale of securities
      11/27/202307:30GLOBETG Therapeutics to Participate in the 6th Annual Evercore..
      11/06/202317:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/03/202307:30GLOBETG Therapeutics to Participate in the 5th Annual Guggenheim..
      11/01/202307:33EDGAR2Form 8-K - Current report
      11/01/202307:30GLOBETG Therapeutics Provides Business Update and Reports Third..
      10/30/202307:30GLOBETG Therapeutics to Host Conference Call on Third Quarter..
      10/12/202311:00GLOBETG Therapeutics Announces Presentation of Data for BRIUMVI..
      10/11/202310:30GLOBETG Therapeutics Announces Presentation of Data for BRIUMVI..
      10/02/202307:30GLOBETG Therapeutics Announces Schedule of Data Presentations for..
      9/29/202317:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/22/202307:30GLOBETG Therapeutics to Participate in the 2023 Cantor Global..
      9/07/202307:30GLOBETG Therapeutics to Participate in the H.C. Wainwright 25th..
      8/14/202309:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/04/202316:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      8/01/202307:29EDGAR2Form 8-K - Current report
      8/01/202307:15GLOBETG Therapeutics Provides Business Update and Reports Second..
      8/01/202307:00GLOBETG Therapeutics and Neuraxpharm Announce Ex-US..
      7/31/202308:30GLOBETG Therapeutics to Host Conference Call on Second Quarter..
      6/05/202307:30GLOBETG Therapeutics to Participate in the 2023 Jefferies..
      6/02/202309:15GLOBETG Therapeutics Announces Presentation of Data from the..
      6/01/202309:15GLOBETG Therapeutics Announces European Commission Approval for..
      5/31/202307:30GLOBETG Therapeutics Announces Data from the ULTIMATE I & II..
      5/04/202307:30GLOBETG Therapeutics to Participate in the Bank of America..
      5/01/202307:30GLOBETG Therapeutics Provides Business Update and Reports First..
      4/28/202316:30GLOBETG Therapeutics to Host Conference Call on First Quarter..

      Your Recent History

      NASDAQ
      TGTX
      TG Therapeutics
      Delayed Upgrade Clock